BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Triad Therapeutics, Inc. 

Press releases archived for reference only.
9381 Judicial Drive, Suite 200
San Diego  California  92121  U.S.A.
Phone: 858-457-0100 Fax: 858-457-7893


SEARCH JOBS


Industry
Biotechnology






 Company News
Triad Therapeutics, Inc. Release: Aperture Health, Inc. Seeks to Become a Leading Partner for Accountable Care Organizations 6/7/2012 11:06:30 AM    More...
Triad Therapeutics, Inc. Release: Aperture Health, Inc. Announces Certification to Provide Medication Therapy Management in the Home 4/24/2012 9:52:35 AM    More...
Triad Therapeutics, Inc. Release: Aperture Health, Inc. Enters Into Discussions to Form a Joint Venture to Offer Its' Services to the Pet Med Marketplace 2/1/2012 10:42:57 AM    More...
Arisaph Pharmaceuticals Reports On Promising Results Presented At American Heart Association: Novel Apo A-I Mimetic Peptide Significantly Inhibits Atherosclerosis In Preclinical Animal Study 11/14/2005 1:33:25 PM    More...
Triad Therapeutics, Inc. Reports Sale Of p38 Kinase Inflammation Program To Novartis Pharma AG (NVS); $66 Million 10/19/2005 5:12:23 PM    More...

//-->